Montreal, June 4, 2024 – ISOLOGIC Innovative Radiopharmaceuticals is investing $29.9 million to support the growth of the radiopharmaceutical industry and to reinforce its critical role in the field of nuclear medicine and the Canadian medical isotope supply chain as part of Quebec’s life sciences ecosystem.
Approximately $19 million will be devoted to the expansion and modernization of the Lachine borough site, and $11 million will be used to purchase state of the art equipment which includes a 18 MeV cyclotron which will be operational from the first quarter of 2026. This investment will help add redundancy to the supply chain and meet the growing demand for critically important PET diagnostic radioisotopes in both Quebec and across Canada.
Read the press release for more info here https://www.newswire.ca/news-releases/isologic-makes-29-9-million-investment-in-advanced-isotope-production-facility-in-quebec-850041864.html